World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
133
Citations
78355
World Ranking
2201
National Ranking
1243

Overview

Alan W. Partin is affiliated with Johns Hopkins University School of Medicine in the United States. Their research primarily focuses on Medicine, with significant contributions to Pulmonary and Respiratory Medicine, Cancer Research, Surgery, Molecular Biology, and Oncology. The scientist's work covers several topics including Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Cancer, Lipids, and Metabolism, Bladder and Urothelial Cancer Treatments, Urologic and reproductive health conditions, Cancer-related molecular mechanisms research, and Advanced Proteomics Techniques and Applications.

Frequent publication venues for Alan W. Partin include Urology, The Journal of Urology, British Journal of Urology, Journal of Clinical Oncology, and Prostate Cancer and Prostatic Diseases. Collaborations are common with several co-authors such as Brent K. Hollenbeck, Edmund Infertility, Wesley Robotics, Alan Wein, and Laparoscopy Linda.

Recent papers published by Alan W. Partin include:

  • T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer, 2020, Clinical Cancer Research
  • Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death, 2021, Journal of Clinical Oncology
  • Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies, 2021, Prostate Cancer and Prostatic Diseases
  • Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer, 2021, PLoS ONE
  • Transperineal Prostate Biopsy Improves the Detection of Clinically Significant Prostate Cancer among Men on Active Surveillance, 2020, The Journal of Urology

Alan W. Partin has contributed to book publications as well, including the "Campbell-Walsh-Wein urology twelfth edition review" published by Elsevier BV in 2020.

Best Publications

  • Natural history of progression after PSA elevation following radical prostatectomy.

    Charles R. Pound;Alan W. Partin;Mario A. Eisenberger;Daniel W. Chan

  • Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi- institutional update

    Alan W. Partin;Michael W. Kattan;Eric N. P. Subong;Patrick C. Walsh

  • Risk of Prostate Cancer-Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy

    Stephen J. Freedland;Elizabeth B. Humphreys;Leslie A. Mangold;Mario Eisenberger

  • Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease: A Prospective Multicenter Clinical Trial

    W.J. Catalona;A.W. Partin;K.M. Slawin;M.K. Brawer

  • The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

    Alan W. Partin;John Yoo;H. Ballentine Carter;Jay D. Pearson

  • Contemporary Update of Prostate Cancer Staging Nomograms (Partin Tables) for the New Millennium

    Alan W Partin;Leslie A Mangold;Dana M Lamm;Patrick C Walsh

  • Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

    Misop Han;Alan W. Partin;Charles R. Pound;Jonathan I. Epstein

  • Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

    Rong Hu;Thomas A. Dunn;Shuanzeng Wei;Sumit Isharwal

  • Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

    Julius Gudmundsson;Patrick Sulem;Andrei Manolescu;Laufey T Amundadottir

  • Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate Cancer

    Misop Han;Alan W Partin;Marianna Zahurak;Steven Piantadosi

  • PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOING

    Thomas J. Polascik;Joseph E. Oesterling;Alan W. Partin

  • Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.

    Patrick C. Walsh;Alan W. Partin;Jonathan I. Epstein

  • Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia

    Alan W. Partin;H. Ballentine Carter;Daniel W. Chan;Jonathan I. Epstein

  • Germline Mutations in HOXB13 and Prostate-Cancer Risk

    Patrick C. Walsh

  • Prognostic Gleason grade grouping: Data based on the modified Gleason scoring system

    Phillip M. Pierorazio;Patrick C. Walsh;Alan W. Partin;Jonathan I. Epstein

  • Prostate-specific Antigen After Anatomic Radical Retropubic Prostatectomy. Patterns of Recurrence and Cancer Control

    Charles R. Pound;Alan W. Partin;Jonathan I. Epstein;Patrick C. Walsh

  • Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy

    Bruce J. Trock;Misop Han;Stephen J. Freedland;Elizabeth B. Humphreys

  • Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years

    A W Partin;C R Pound;J Q Clemens;J I Epstein

  • Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy

    Scott E. Eggener;Peter T. Scardino;Patrick C. Walsh;Misop Han

  • Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update.

    Walsh Pc

Frequent Co-Authors

Jonathan I. Epstein
Jonathan I. Epstein Johns Hopkins University
Patrick C. Walsh
Patrick C. Walsh Johns Hopkins University
Bruce J. Trock
Bruce J. Trock Johns Hopkins University
Daniel W. Chan
Daniel W. Chan Johns Hopkins University School of Medicine
Lori J. Sokoll
Lori J. Sokoll Johns Hopkins University School of Medicine
H. Ballentine Carter
H. Ballentine Carter Johns Hopkins University School of Medicine
Stephen J. Freedland
Stephen J. Freedland Cedars-Sinai Medical Center
Mario A. Eisenberger
Mario A. Eisenberger Johns Hopkins University
Edward M. Schaeffer
Edward M. Schaeffer Northwestern University
Stacy Loeb
Stacy Loeb New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medical careers beyond traditional MD paths? Numerous online healthcare degrees offer flexible, accredited pathways to rewarding positions in the U.S. healthcare system. For those fascinated by the business and leadership side of medicine, a healthcare administration degree online accredited program can open doors to roles in hospital management and healthcare policy.

Registered nurses aiming to expand their clinical expertise may consider transitioning from rn to np positions through bridge programs, offering a streamlined route to becoming a nurse practitioner. If your interests lie in wellness and nutrition, pursuing an online bs in nutrition can prepare you for roles as a dietitian, nutritionist, or health coach.

For those seeking advanced leadership, consider the top cahme-accredited mha programs focused on hospital administration and healthcare improvement. These online degrees provide flexibility and the opportunity to balance study with work, accelerating your pathway to a successful healthcare career.

Best Scientists Citing Alan W. Partin

Trending Scientists

Recently Published Articles